UPenn's Bruce Levine catches us up on the latest in cell therapy at #ATW23.

UCSF's Nicole Paulk discusses AAV as a gene therapy vector at Advanced Therapies Week in Miami Beach.

Parker Institute's John Connolly provides an update on the latest in cancer immunotherapy at #JPM23.

BTIG biotechnology analyst Justin Zelin gives his take on the news at #JPM23.

Centerview Partners' Eric Tokat talks about the M&A deals that have been announced at #JPM23.

Arie Belldegrun talks about navigating tough times during biotech downturns and allogeneic CAR-T.

Luke Timmerman fills us in on the latest at the Timmerman Report and his upcoming climb for cancer research of Mount Kilimanjaro at #JPM23.

Jorge Conde tells us about a16z's philosophy for investing in healthcare at #JPM23.

Flagship Pioneering’s Noubar Afeyan gives his take on the biotech sector for the year ahead at #JPM23.

R.W. Baird Senior Research Analyst Brian Skorney speaks first with BiotechTV on the Monday morning JPM23.

Flagship Pioneering's Noubar Afeyan describes what it was like to navigate the pandemic as Chairman of Moderna.